Ardelyx, Inc. (ARDX)
2.88
-0.11
(-3.68%)
USD |
NASDAQ |
Nov 06, 16:00
2.85
-0.03
(-1.04%)
After-Hours: 20:00
Ardelyx Total Long Term Debt (Quarterly) : 254.76M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 254.76M |
| June 30, 2026 | 254.64M |
| March 31, 2026 | 206.75M |
| December 31, 2025 | 206.48M |
| September 30, 2025 | 206.18M |
| June 30, 2025 | 205.46M |
| March 31, 2025 | 153.81M |
| December 31, 2024 | 151.88M |
| September 30, 2024 | 101.92M |
| June 30, 2024 | 101.34M |
| March 31, 2024 | 100.61M |
| December 31, 2023 | 51.55M |
| September 30, 2023 | 30.12M |
| June 30, 2023 | 30.80M |
| March 31, 2023 | 31.69M |
| December 31, 2022 | 43.82M |
| September 30, 2022 | 33.42M |
| June 30, 2022 | 34.23M |
| March 31, 2022 | 34.95M |
| December 31, 2021 | 42.01M |
| September 30, 2021 | 62.14M |
| June 30, 2021 | 62.79M |
| March 31, 2021 | 51.41M |
| December 31, 2020 | 51.20M |
| September 30, 2020 | 50.68M |
| Date | Value |
|---|---|
| June 30, 2020 | 51.06M |
| March 31, 2020 | 51.58M |
| December 31, 2019 | 52.09M |
| September 30, 2019 | 52.57M |
| June 30, 2019 | 53.03M |
| March 31, 2019 | 53.47M |
| December 31, 2018 | 49.21M |
| September 30, 2018 | 49.02M |
| June 30, 2018 | 48.84M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Capricor Therapeutics, Inc. | 89.56M |
| Mirum Pharmaceuticals, Inc. | 740.97M |
| Compass Therapeutics, Inc. | 7.996M |
| ARS Pharmaceuticals, Inc. | 121.81M |
| Sionna Therapeutics, Inc. | 6.692M |